BCRX Stock Analysis: Buy, Sell, or Hold?
BCRX - BioCryst Pharmaceuticals Inc
$9.12
0.17 (1.84%)
▲
5d:
+7.24%
30d:
+3.93%
90d:
-7.08%
BUY
HIGH Confidence
Analysis Updated: Jun 17, 2026 12:00 AM ET
Earnings: Aug 03, 2026
Smart Money Distribution
None View Scanner →
Strength: 7.6/10
Get Alerted When BCRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: BCRX trading at deep discount. Market pricing in -7.5% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: BCRX trading at deep discount. Market pricing in -7.5% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$19.94
Based on 12.2% avg growth
INTRINSIC VALUE TODAY
$12.38
26.4% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 16.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BCRX is currently trading at $9.12, which is considered slightly high relative to its 30-day fair value range of $8.36 to $9.10. From a valuation perspective, the stock is trading at a discount (Forward PE: 13.2) compared to its historical average (16.6). Remarkably, the market is currently pricing in an annual earnings decline of 7.5% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, BCRX is in a uptrend. Immediate support is located at $8.10, while resistance sits at $9.54.
Market Sentiment: BCRX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $21.30 (+138.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, BCRX is in a uptrend. Immediate support is located at $8.10, while resistance sits at $9.54.
Market Sentiment: BCRX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $21.30 (+138.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$8.36 -
$9.10
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
76.2%
All Signals
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 138.0% below Wall St target ($21.30)
Trading Range Analysis
30-Day Trading Range
$8.36 -
$9.10
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$8.10
Resistance Level
$9.54
Current Trend
Uptrend
Technical data as of
Jun 18, 2026
Fundamental Context
Forward P/E (Next Year Est.)
13.16
Wall Street Target
$21.30
(+138.0%)
Revenue Growth (YoY)
7.5%
Profit Margin
-51.7%
Valuation Discount vs History
-7.5% cheaper
PE vs Historical
13.2 vs 16.6
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-7.5%
(market-implied from PE analysis)
1-Year Target
$8.28
(-8%)
2-Year Target
$7.66
(-14%)
3-Year Target
$7.08
(-21%)
3-Yr Target (if PE normalizes)
(PE: 13→17)
$8.93
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 20.4%)
$25.82
(+189%)
Base:
(SPY PE: 13.2, Growth: 20.4%)
$15.60
(+74%)
Bear:
(PE: 11.2, Growth: 20.4%)
$13.26
(+48%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 13.2 to 16.6
Stabilization Target:
$11.29
(+26.1%)
PE Expansion Potential:
+26.1%
Share & Embed Analysis
Last updated: June 18, 2026 1:08 PM ET
Data refreshes hourly during market hours. Next update: 2:08 PM
Data refreshes hourly during market hours. Next update: 2:08 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BCRX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Alane P Barnes
SELL
150000 shares
2026-03-16
Alane P Barnes
SELL
21773 shares
2025-12-22
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$193 | 60 HOLD |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$665 | 67 BUY |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$105 | 60 HOLD |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$125 | 57 HOLD |
|
AQST
Aquestive Therapeutics I… |
STRONG BUY
9 analysts |
$9 | 66 BUY |
Advanced BCRX Option Strategies
Professional options setups generated by AI based on today's BCRX price and gamma walls.
